Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody-Reference-Cited by-同舟云学术

Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody

Published:2018-02-26 Issue:4 Volume:15 Page:1526-1533
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Yoyen-Ermis Digdem¹,Ozturk Kivilcim²,Kursunel M. Alper¹,Aydin Cisel³,Ozkazanc Didem¹,Gurbuz Mustafa Ulvi⁴,Uner Aysegul³,Tulu Metin⁴,Calis Sema²,Esendagli Gunes¹^ORCID

Affiliation:

1. Cancer Institute, Department of Basic Oncology, Hacettepe University, 06100 Ankara, Turkey

2. Faculty of Pharmacy, Department of Pharmaceutical Technology, Hacettepe University, 06230 Ankara, Turkey

3. Medical Faculty, Department of Pathology, Hacettepe University, 06100 Ankara, Turkey

4. Faculty of Arts and Sciences, Department of Chemistry, Yıldız Technical University, 34349 Istanbul, Turkey

Funder

European Cooperation in Science and Technology

T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b01075

Reference44 articles.

1. The Tumor Macroenvironment

2. Homeostatic and pathogenic extramedullary hematopoiesis

3. The Terminology Issue for Myeloid-Derived Suppressor Cells

4. Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

5. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective Role of Polyamidoamine (PAMAM) Dendrimer Functionalized Nanomaterials in Anticancer Applications;ChemistrySelect;2023-05-15

2. Polymeric Nanomaterials: Fundamentals and Therapeutic Applications;Nanomaterial-Based Drug Delivery Systems;2023

3. Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy;Frontiers in Nanotechnology;2022-06-08

4. Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma;Expert Opinion on Drug Delivery;2022-03-01

5. PAMAM dendrimers and prospects of their application in medicine;Medicine of Extreme Situations;2022-03